Claudius Rudin

First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial

Gareth J. Morgan, Faith E. Davies, Walter M. Gregory et al. · The Lancet · 2010 · 571 citations · Full text

Medicine, Oncology, Pharmacotherapy +8

The role of maintenance thalidomide therapy in multiple myeloma: MRC Myeloma IX results and meta-analysis

Gareth J. Morgan, Walter M. Gregory, Faith E. Davies et al. · Blood · 2011 · 329 citations

Medicine, Hematology, Oncology +16

Cyclophosphamide, thalidomide, and dexamethasone (CTD) as initial therapy for patients with multiple myeloma unsuitable for autologous transplantation

Gareth J. Morgan, Faith E. Davies, Walter M. Gregory et al. · Blood · 2011 · 196 citations · Full text

Medicine, Hematology, Oncology +15

Effects of zoledronic acid versus clodronic acid on skeletal morbidity in patients with newly diagnosed multiple myeloma (MRC Myeloma IX): secondary outcomes from a randomised controlled trial

Gareth J. Morgan, J. Anthony Child, Walter M. Gregory et al. · The Lancet Oncology · 2011 · 163 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Autologous stem cell transplantation for enteropathy-associated T-cell lymphoma: a retrospective study by the EBMT

Esa Jantunen, Ariane Boumendil, Hervé Finel et al. · Blood · 2013 · 89 citations · Full text

Medicine, Immunology, Oncology +9